Evidence map›Paper›PMID 27016238›Full record

ArticleCurrent microbiology2016

Temperature Change Induces the Expression of vuuA Encoding Vulnibactin Receptor and crp Encoding Cyclic AMP Receptor Protein in Vibrio vulnificus.

Choon-Mee Kim, Young-Joon Ahn, Seong-Jung Kim, Dae-Heung Yoon, Sung-Heui Shin

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Choon-Mee KimPremedical Sciences, Chosun University Medical School, Gwangju, 501-759, Republic of Korea.
Young-Joon AhnPremedical Sciences, Chosun University Medical School, Gwangju, 501-759, Republic of Korea.
Seong-Jung KimDepartment of Emergency Medicine, Chosun University Medical School, Gwangju, 501-759, Republic of Korea.
Dae-Heung YoonDepartment of Emergency Medicine, Chosun University Medical School, Gwangju, 501-759, Republic of Korea.
Sung-Heui ShinPremedical Sciences, Chosun University Medical School, Gwangju, 501-759, Republic of Korea. shsin@chosun.ac.kr.
Chosun University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Upon entering the human body, Vibrio vulnificus, a gram-negative marine bacterium, must withstand a temperature change (TC) from 25 to 37 °C. This bacterium acquires iron mainly via the vulnibactin receptor (VuuA)-mediated iron uptake system (IUS), which is under the positive control of cyclic AMP receptor protein (CRP), a global regulator responsible for catabolite repression. In this study, we examined the effect of TC on the expression of vuuA and crp, and the reciprocal relation between VuuA-mediated IUS and CRP under iron-limited conditions. Iron limitation increased vuuA expression but decreased crp expression. TC resulted in increased vuuA and crp expression. A crp or vuuA mutation reciprocally decreased vuuA or crp expression. TC could increase vuuA or crp expression even in a crp- or vuuA-mutated background. These results indicate that TC increases the expression of both vuuA and crp by facilitating metabolism under iron-limited conditions, and that CRP and VuuA-mediated IUS interact coordinately toward optimal metabolism in V. vulnificus.

Indexed as

Gene Expression Regulation, BacterialAmidesBacterial ProteinsCyclic AMP Receptor ProteinHumansOxazolesTemperatureVibrio InfectionsVibrio vulnificusAmidesBacterial ProteinsCyclic AMP Receptor ProteinOxazolesvulnibactin

Identifiers

PMID27016238
OpenAlexW2319714357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.